Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

Spin Out - Diagnostics division...may acquire additional diagnostic assets that would help bolster a successful Diagnostic division spin-out. What other surprises does Mgt. have coming.....sounds like something is imminent...:)

Per the Blog:
"As the launch of LymPro nears, the company is also looking to maximize the value of the investment we have made in the asset since acquiring it in late 2012. As a holding company, Amarantus is continuing to evaluate methods of returning value to shareholders, including a potential spinoff of the company’s diagnostic division. In addition to LymPro and our NuroPro Parkinson’s diagnostic, we are actively evaluating additional complementary late-stage neurology-focused diagnostic assets that would bolster our diagnostic division and make for a successful ‘spin-out’ while concurrently returning value to our shareholders. We believe we will be able to execute on this strategy in the near-term.

Happy Thanksgiving to everyone..and to a prosperous and succesfull 2015.